Narcan will soon be available over the counter

The opioid overdose antidote will be sold in stores as soon as next week

Credit: WSBTV Videos

Potent synthetic opioid Fentanyl is making its way into street drugs sold in metro Atlanta

In a statement on Wednesday, Emergent BioSolutions, the manufacturer of naloxone — an opioid overdose antidote — announced that its medicine will be available over the counter in stores as early as next week. The Narcan-branded naloxone will have a suggested retail price of $44.99 for a carton featuring two doses, the company announced in the news release.

“A steadfast commitment to expanding access to naloxone has always been at the forefront of our work to help save lives and we’re proud to bring Narcan Nasal Spray to many, many more places,” Paul Williams, Emergent BioSolutions senior vice president, said.

“Expanding availability to online and in-store shelves, increasing awareness and education to reduce stigma, and calling on the public to be prepared, is additive to the current work Emergent does every single day to stem the tide of this public health threat. On the eve of International Overdose Awareness Day, we stand by our ongoing efforts with advocates, patients, customers and policy stakeholders to implement efforts that enhance naloxone distribution to all those in need.”

The U.S. Food and Drug Administration first approved the over-the-counter naloxone nasal spray in late March.

“The FDA remains committed to addressing the evolving complexities of the overdose crisis,” FDA commissioner Robert M. Califf, M.D., said in a news release. “As part of this work, the agency has used its regulatory authority to facilitate greater access to naloxone by encouraging the development of and approving an over-the-counter naloxone product to address the dire public health need.

“Today’s approval of OTC naloxone nasal spray will help improve access to naloxone, increase the number of locations where it’s available and help reduce opioid overdose deaths throughout the country. We encourage the manufacturer to make accessibility to the product a priority by making it available as soon as possible and at an affordable price.”

The U.S. saw more than 100,000 fatal drug overdoses in the year ending October 2022. The primary cause of the overdoses was synthetic opioids, including fentanyl.